Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Lower limb amputation for arteriosclerosis obliterans]

G Kenan, B Schwartz, M Mozes

    Harefuah
    |February 15, 1971
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A phase III randomized trial of BAY 12-9566 (tanomastat) as maintenance therapy in patients with advanced ovarian cancer responsive to primary surgery and paclitaxel/platinum containing chemotherapy: a National Cancer Institute of Canada Clinical Trials Group Study.

    Gynecologic oncology·2006
    Same author

    Pooled safety analysis of BAY 43-9006 (sorafenib) monotherapy in patients with advanced solid tumours: Is rash associated with treatment outcome?

    European journal of cancer (Oxford, England : 1990)·2006
    Same author

    How often should a port-A-cath be flushed?

    Cancer investigation·2005
    Same author

    An NCIC-CTG phase I dose escalation pharmacokinetic study of the matrix metalloproteinase inhibitor BAY 12-9566 in combination with doxorubicin.

    Investigational new drugs·2005
    Same author

    HTS magnetometers for fetal magnetocardiography.

    Neurology & clinical neurophysiology : NCN·2005
    Same author

    Phase I study to determine the safety and pharmacokinetics of the novel Raf kinase and VEGFR inhibitor BAY 43-9006, administered for 28 days on/7 days off in patients with advanced, refractory solid tumors.

    Annals of oncology : official journal of the European Society for Medical Oncology·2005
    Same journal

    [Tennis Elbow Among Players].

    Harefuah·2026
    Same journal

    [Internal Medicine - My Mission].

    Harefuah·2026
    Same journal

    [Treatment of Morbid Obesity in Israel: GLP-1 Agonists Versus Bariatric Surgery - Clinical and Economic Aspects].

    Harefuah·2026
    Same journal

    [Baby steps: Post-operative Treatment Recommendations for Pediatric Tracheostomy in Israel].

    Harefuah·2026
    Same journal

    [Mastoiditis Caused by Fusobacterium Necrophorum: an Unusual Pathogen in a Well-Known Disease].

    Harefuah·2026
    Same journal

    [Cochlear Implantation in Single-Sided Deafness - Six Years of Follow-Up from Diagnosis and Consistent Use, Through Dedicated and Creative Auditory Learning, to the Development of Bilateral Central Processing Abilities].

    Harefuah·2026
    See all related articles